- 全部删除
您的购物车当前为空
Losartan potassium (DuP-753 potassium) 是一种血管紧张素 II 受体 1 型(AT1)拮抗剂,能够与血管紧张素 II 与 AT1 的结合竞争,其 IC50=20 nM。

Losartan potassium (DuP-753 potassium) 是一种血管紧张素 II 受体 1 型(AT1)拮抗剂,能够与血管紧张素 II 与 AT1 的结合竞争,其 IC50=20 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 mg | ¥ 115 | In stock | |
| 100 mg | ¥ 153 | In stock | |
| 500 mg | ¥ 328 | In stock | |
| 1 g | ¥ 418 | In stock | |
| 5 g | ¥ 993 | In stock | |
| 10 g | ¥ 1,460 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 413 | In stock |
Losartan potassium 相关产品
| 产品描述 | Losartan potassium (DuP-753 potassium) , an Angiotensin II Receptor Blocker, selectively and competitively blocks the binding of angiotensin II to the angiotensin I (AT1) receptor. |
| 靶点活性 | AT1 receptor:20 nM |
| 体外活性 | Losartan 与血管紧张素II竞争性地结合AT1受体。其抑制血管紧张素II结合50%所需浓度(IC50)为20 nM[1]。Losartan (40μM)影响ISC,但可阻止ANGII对ISC的作用[2]。Losartan 显著降低血管紧张素II介导的子宫内膜癌细胞增殖。Losartan 与抗miR-155联合使用,相比单药治疗具有更显著的抑制增殖效果[3]。 |
| 细胞实验 | An MTT assay is used to measure cell proliferation and viability. For the assay, 5000 cells in 200?μL media per well are seeded in a 96 well plate. After overnight incubation to allow for cell attachment, the medium is removed by suction. MTT at 1?mg/mL concentration in serum-free medium is added and then incubated for 4?h at 37°C. After removal of MTT solution, 100?μL of DMSO is added to dissolve formazan crystals. Absorbance at 570?nm and at 600?nm as a reference is then measured using a microplate reader. The difference in absorbance is thus relative to the extent of cell survival. |
| 别名 | 洛沙坦钾, 氯沙坦钾, MK 954, DuP-753 potassium, DuP 753 |
| 分子量 | 461.01 |
| 分子式 | C22H22ClKN6O |
| CAS No. | 124750-99-8 |
| Smiles | [K+].CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[n-]1 |
| 密度 | 0.986?g/mL?at 25?°C(lit.) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 46.1 mg/mL (100 mM), Sonication is recommended. DMSO: 55 mg/mL (119.3 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容